Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Journal of Human Genetics

• Publication date

  2018-03-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/s41431-017-0057-3PMID 29599518PMCID PMC6018744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

  2017cited by this paper
• Are Small Breast Cancers Good because They Are Small or Small because They Are Good?

  2017cited by this paper
• Development and validation of contouring guidelines for post-cystectomy adjuvant radiation of bladder cancer.

  2016cited by this paper
• Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial

  2016cited by this paper
• Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

  2016cited by this paper
• When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer

  2016cited by this paper
• Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.

  2015cited by this paper
• Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial

  2014cited by this paper
• Inducing labour reduces risk of caesarean delivery by 12%, finds analysis

  2014cited by this paper
• Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis

  2014cited by this paper
• Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility

  2014cited by this paper
• Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

  2013cited by this paper
• BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening

  2012cited by this paper
• Cancer genetic risk assessment for individuals at risk of familial breast cancer.

  2012cited by this paper
• How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

  2012cited by this paper
• Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers

  2011cited by this paper
• The role of BRCA mutation testing in determining breast cancer therapy

  2010cited by this paper
• Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

  2009cited by this paper
• Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review.

  2009cited by this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cited by this paper
• BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy

  2007cited by this paper
• Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.

  2007cited by this paper
• Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer.

  2006cited by this paper
• Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.

  2004cited by this paper
• Validation of a Decision Regret Scale

  2003cited by this paper
• Applied Longitudinal Data Analysis

  2003cited by this paper
• A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.

  2002cited by this paper
• Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer

  2001cited by this paper
• The new genetics: Psychological responses to genetic testing

  1998cited by this paper
• Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

  1994cited by this paper

• The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing

  2025cites this paper
• Designing and evaluation of the effect of community-based intervention on breast self-examination among reproductive-aged women in Ethiopia: A Cluster Randomized Controlled Trial

  2025cites this paper
• Germline variant spectrum of hereditary cancer susceptibility genes in a Chinese cohort

  2025cites this paper
• A scoping review of decision regret in non-communicable diseases: The emerging roles of patient-clinician communication, psychological aspects, and medical outcomes.

  2024cites this paper
• Clinical Impact of Constitutional Genomic Testing on Current Breast Cancer Care.

  2024cites this paper
• Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular Breast Cancer.

  2023cites this paper
• Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC).

  2023cites this paper
• Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care

  2023cites this paper
• Adjuvant vs. neoadjuvant chemotherapy: quality of life and psychosocial variables in women with breast cancer

  2022cites this paper
• Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk

  2022influential citation
• Heterogeneity of posttraumatic stress, depression, and fear of cancer recurrence in breast cancer survivors: a latent class analysis

  2022cites this paper
• Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions.

  2021cites this paper
• Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning

  2021cites this paper
• Patient-Reported Outcomes following Genetic Testing for Familial Hypercholesterolemia, Breast and Ovarian Cancer Syndrome, and Lynch Syndrome: A Systematic Review

  2021influential citation
• Psychological distress in newly diagnosed breast cancer patients: an observational study comparing those at high risk of hereditary cancer with those of unknown risk

  2020cites this paper
• Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review

  2020cites this paper
• How to improve the identification of patients with cancer eligible for genetic counselling?

  2020cites this paper
• Genetic Counseling Referrals and Genetic Profiles of Male and Young Female Breast Cancer Populations

  2019cites this paper